Company / FCF Margin
Whitehawk Therapeutics, Inc. FCF Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-235.6%
FY2025
5-year range
-357.7% / -87.4%
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -357.7% to -235.6% over the past 2 years.
Based on SEC 10-K filings.
-235.6% in FY2025 with a 3-year CAGR of -75.1%.
Improved from -357.7% to -235.6% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -75.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 9.9% year-over-year.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -235.6% | +9.9% |
| FY2024 | -261.3% | +27.0% |
| FY2023 | -357.7% | -122.9% |
| FY2022 | -160.5% | -83.6% |
| FY2021 | -87.4% | - |
| FY2020 | - | - |
| FY2019 | -29.0% | +98.0% |
| FY2018 | -1416.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026